Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going.
Alessandro CoppolaTommaso FarolfiVincenzo La VaccaraImmacolata IannoneFrancesco GiovinazzoElena PanettieriMariarita TaralloRoberto CammarataRoberto CoppolaDamiano CaputoPublished in: Journal of clinical medicine (2023)
The future challenge could be to identify only selected patients who will really benefit from upfront surgery despite a combination of NAD and surgery.